Recent Articles

• 
  Global Expansion

  POSCO International Acquires Indonesian Palm Firm for KRW 1.3 Trillion

  POSCO International acquired Sampoerna Agro, a major palm (a type of palm tree, pictured) company in Indonesia, on the 19th. With the completion of a palm oil refinery in the region, the company can now independently handle everything from palm seed development to the production of palm oil, a raw m

  2025.11.21
• 
  Medical / Research

  Korean Study: Inflammation a Key Depression Cause

  Provided by KAIST. Research findings have indicated that immune imbalance affects the onset of depression. It suggests that not only issues of the mind or brain but also inflammatory responses within the body are among the main causes of depression. These findings are expected to contribute to the d

  2025.11.21
• 
  Bio / Investment

  Seo Jung-jin: KRW 5.4 Trillion Biopharma Investment

  Celltrion has announced plans to invest KRW 4 trillion in South Korea and KRW 1.4 trillion in the United States to expand its manufacturing facilities for biosimilars and new drug development. The company aims to mitigate tariff risks by dualizing production channels, with products for the U.S. mark

  2025.11.20
• 
  K-Medical

  Open Healthcare Opens Korean Medical Center in Almaty

  Open Healthcare Korean Medical Center. Provided by Open Healthcare Global healthcare company Open Healthcare announced on the 19th that it held an opening ceremony for the 'Korean Medical Center (KMC)' in Almaty, Kazakhstan. Representatives from Seegene Medical Foundation, a disease testing speciali

  2025.11.19
• 
  Medical Conference

  Seegene Medical Foundation to Join 2025 KSLM Conference

  Seegene Medical Foundation participated in the '2025 Korean Society for Laboratory Medicine International Conference' held last month. Provided by Seegene Medical Foundation Seegene Medical Foundation announced on the 18th that it participated in the '2025 Korean Society for Laboratory Medicine Inte

  2025.11.18
• 
  Bio

  "Korean Bio Platforms Attract Global Pharma Interest"

  The domestic bio market is experiencing a revival. Recently, domestic bio companies have succeeded in exporting technology worth trillions of KRW, leading to a diversification of investment funds from semiconductor stocks to bio stocks. The driving force behind the 'second bio spring' following the

  2025.11.18
• 
  MedTech

  Korea University Medical Center Launches Particle Therapy Project

  Provided by Korea University Medical Center Korea University Medical Center announced on the 17th that it will officially commence the 'Particle Therapy Hub Establishment' project, which is expected to mark a new turning point in domestic cancer treatment.A representative from Korea University Medic

  2025.11.17
• 
  Tech / Robot / FDA

  EndoRobotics: Endoscopic Surgery Robot Gains FDA Approval

  "Endorobotics possesses world-class technology based on extensive research by medical professionals and robotics technology."In the early 19th century, doctors used candles and mirrors to look inside the human body. With the introduction of fiber optic technology in the 1950s, endoscopes finally bec

  2025.11.17
• 
  Bio / R&D

  Jefit Wins CES 2026 Innovation Award for Onco-FIT

  Photo courtesy of Zefit Zefit announced on the 17th that it received the Innovation Award in the 'Human Security' category at 'CES 2026', the world's largest IT and electronics exhibition. This award recognizes the innovation of Zefit's patient-customized zebrafish avatar-based anticancer drug sensi

  2025.11.17
• 
  Bio / R&D

  Alteogen Eyes KOSPI, Targets 60% Profit Margin

  Alteogen Headquarters and Research Institute Alteogen announced on the 14th through a disclosure that it achieved consolidated sales of KRW 49 billion and an operating profit of KRW 26.7 billion in the third quarter of this year. Compared to last year, sales grew by 900%, and operating profit turned

  2025.11.14